London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think they need start to advertise through various channels like RNS that there is a link between and COVID-19 and Fruitflow. Once they start advertise then people will show interest. I know they need to do a full clinical trail to make a formal claim that will probably rocket the SP. However they simply could provide a RNS. Please look at Sareum. Recently there is a publication in nature magazine and Sareum provide a RNS based on that publication. I hope IF is following up all these links rather than taking it is a bit easy as he got £1m in bank.
According to the profs, Covid will be an an ongoing factor, with variants continuing. The vaccines won't eliminate it. So the sticky blood effect should be well worth continued studies if they can be afforded. Something that would fund further projects would be the most welcome factor, i.e. product launches by By Health
We all hope there is no future in CV. As such I believe we should concentrate any trials budget on pollution and exercise.
W£
(wouldn’t want to out of this over weekend)
No it's a double blind stage they are doing. Seems to be a little slim on participants but these are different times were in
Quite. That's the human trials that are necessary as a first stage. Double blind tests after. To conduct such tests on recovering Covid patients would no doubt require getting in a queue of other pharma offerings. Not impossible, but not something that could be done in a flash either. The company would be in all sorts of legal tangles if claims were made on the back of early theory.
We all believe that the positive effect on bloodflow afforded by Fruitflow would be beneficial to Covid sufferers, but belief and clinical proof are very different IMHO
Not sure about that Alfista. Another pharma I'm in are conducting a single trial with only 45 patients enlisted. If it shows positive results I'm pretty sure it'll be hyped up and rolled out, such is the nature of the crisis were in.
We simply can't make such a claim unless a huge amount of clinical trials are conducted. Scientific papers are not commercial proof.
gixer,
I also hope so there is a valid reason for not referencing that paper not IF is lazy to do anything as he got £1m in the bank account. I strongly believe it is worth for a RNS to show the world that we have a wonderful product fruitflow to help people with COVID-19. Hope there is a fight between DSM and BY-Health to take the COVID link in future as DSM's contract is going to end next hear and BY-Health spent a lots of their money in 9 clinical trials. Very interesting time ahead.
Yes Gixer, should have put when.
kievsky, I think you mean when :)
Dont be so sure. If China comes off this will fly. Then Bi-Health will almost certainly buy us out. Lets see who is laughing then.
Fruitflow - probably the best kept secret in the world
To be honest, I find it a bit strange that the company has yet to make any reference to the Fruitflow / Covid
Med Hypotheses by O'Kennedy and Duttaroy. They where all over the Frontiers review, included it on the FF+ and PXS websites and even in RNS's.
I can only guess that they are holding it back for a reason.
Its has popped up in quite a few places
https://www.google.co.uk/search?q=%22Platelet+hyperactivity+in+COVID-19%22+%22fruitflow%22&sxsrf=ALeKk02m5WphvOBVBtenHwQYDMXkfvxSfg:1611298407128&ei=Z3YKYISuB9PVgQbY-oiwBA&start=0&sa=N&ved=2ahUKEwjE_bup-q7uAhXTasAKHVg9AkY4FBDy0wN6BAgKEDs&biw=1366&bih=625
Including China
https://www.x-mol.com/paper/1346174925975703552
gixer,
Great find. I think you should be in PXS board to promote the great product fruitflow. Now they need to tweet that Fruitflow will hep people with COVID-19 and refer that paper Asim recently published.
Fruitflow Plus now tweeting.
https://twitter.com/FruitflowPlus
Would this ever go past 1p
Not uncommon for pxs.
Because they can, and do, shift the Bid and Ask any which way.
Could some explain to me,why is there a massive spread,
gixer,
Good find. Probably we need to wait for their explanation.
Thanks 0.79 to sell now
Brokers may have offered more as they had a buy order to fill at 0.95 for 2 million shares.
Assume the 0.85 "sells " from yesterday are buys;or are some brokers very generous
Only guessing but i would say its related.
Not sure why the distributor would need to set up a separate company to sell Fruitflow+ "through its existing network of e-commerce and other sales channels." but maybe that's the way it is????
As for the name change...... Well maybe PXS or more likely DSM didn't want them to use the name Fruitflow as the company and this has maybe caused delays to selling FF+ in China.
Should find out eventually.